REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,106,578 | +10.8% | 19,537 | -1.4% | 0.01% | +16.7% |
Q2 2023 | $2,803,454 | -18.5% | 19,818 | -3.0% | 0.01% | -25.0% |
Q1 2023 | $3,441,110 | -2.0% | 20,439 | -0.5% | 0.02% | -5.9% |
Q4 2022 | $3,511,069 | +1664.4% | 20,551 | +1903.0% | 0.02% | +1600.0% |
Q1 2021 | $199,000 | -73.2% | 1,026 | -73.9% | 0.00% | -66.7% |
Q4 2020 | $743,000 | +28.1% | 3,932 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $580,000 | -24.7% | 3,932 | -36.9% | 0.00% | -25.0% |
Q2 2020 | $770,000 | +169.2% | 6,231 | +110.1% | 0.00% | +100.0% |
Q1 2020 | $286,000 | +71.3% | 2,966 | -46.0% | 0.00% | 0.0% |
Q1 2015 | $167,000 | -68.4% | 5,497 | -79.4% | 0.00% | -71.4% |
Q4 2014 | $528,000 | -0.6% | 26,649 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $531,000 | +15.2% | 26,649 | +31.6% | 0.01% | 0.0% |
Q2 2014 | $461,000 | +77.3% | 20,249 | 0.0% | 0.01% | +75.0% |
Q1 2014 | $260,000 | -5.8% | 20,249 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $276,000 | +22.7% | 20,249 | 0.0% | 0.00% | +33.3% |
Q3 2013 | $225,000 | – | 20,249 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |